• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用温和热疗优化的隐形热敏脂质体触发内容释放。

Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia.

机构信息

Laboratory Experimental Surgical Oncology, Section Surgical Oncology, Department of Surgery, Erasmus Medical Center, Rotterdam, the Netherlands.

出版信息

J Control Release. 2010 Apr 19;143(2):274-9. doi: 10.1016/j.jconrel.2010.01.006. Epub 2010 Jan 13.

DOI:10.1016/j.jconrel.2010.01.006
PMID:20074595
Abstract

Liposomes are potent nanocarriers to deliver chemotherapeutic drugs to tumors. However, the inefficient drug release hinders their application. Thermosensitive liposomes (TSL) can release drugs upon heat. This study aims to identify the optimum 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-PEG(2000) (DSPE-PEG(2000)) concentration in stealth TSL to improve content release efficiency under mild hyperthermia (HT). TSL were prepared with DSPE-PEG(2000) from 1 to 10 mol%, around 80 nm in size. Quenched carboxyfluorescein (CF) in aqueous phase represented encapsulated drugs. In vitro temperature/time-dependent CF release and TSL stability in serum were quantified by fluorometry. In vivo CF release in dorsal skin flap window chamber models implanted with human BLM melanoma was captured by confocal microscopy. In vitro heat triggered CF release increased with increasing DSPE-PEG(2000) density. However, 6 mol% and higher DSPE-PEG(2000) caused CF leakage at physiological temperature. TSL with 5 mol% DSPE-PEG(2000) were stable at 37 degrees C, while released 60% CF in 1 min and almost 100% CF in 1h at 42 degrees C. In vivo optical intravital imaging showed immediate massive CF release above 41 degrees C. In conclusion, incorporation of 5 mol% DSPE-PEG(2000) optimized stealth TSL content release triggered by HT.

摘要

脂质体是一种有效的纳米载体,可将化疗药物递送到肿瘤部位。然而,药物释放效率低下限制了其应用。热敏脂质体(TSL)可以在加热时释放药物。本研究旨在确定隐形 TSL 中最佳的 1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺-N-聚乙二醇(2000)(DSPE-PEG(2000))浓度,以提高温和热疗(HT)下的药物内容物释放效率。使用 DSPE-PEG(2000)从 1 至 10mol%制备 TSL,粒径约为 80nm。水相中的猝灭羧基荧光素(CF)代表包封的药物。通过荧光法定量测量体外温度/时间依赖性 CF 释放和 TSL 在血清中的稳定性。通过共聚焦显微镜捕获植入人 BLM 黑色素瘤的背部皮瓣窗口室模型中的体内 CF 释放。体外热触发 CF 释放随 DSPE-PEG(2000)密度的增加而增加。然而,6mol%及更高浓度的 DSPE-PEG(2000)会导致在生理温度下 CF 泄漏。含 5mol% DSPE-PEG(2000)的 TSL 在 37°C 时稳定,而在 42°C 下 1 分钟内释放 60%CF,1 小时内几乎释放 100%CF。体内光学活体成像显示,在 41°C 以上时立即大量释放 CF。总之,在 HT 触发下,掺入 5mol% DSPE-PEG(2000)可优化隐形 TSL 的内容物释放。

相似文献

1
Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia.采用温和热疗优化的隐形热敏脂质体触发内容释放。
J Control Release. 2010 Apr 19;143(2):274-9. doi: 10.1016/j.jconrel.2010.01.006. Epub 2010 Jan 13.
2
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.温和的热刺激从优化的隐形热敏脂质体中释放阿霉素,改善肿瘤内药物递送和疗效。
J Control Release. 2013 Jun 10;168(2):142-50. doi: 10.1016/j.jconrel.2013.03.011. Epub 2013 Mar 21.
3
Size of thermosensitive liposomes influences content release.脂质体的大小影响内容物的释放。
J Control Release. 2010 Nov 1;147(3):436-43. doi: 10.1016/j.jconrel.2010.08.013. Epub 2010 Aug 19.
4
Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.蛋白质和胆固醇脂质体是热敏脂质体药物释放的介质。
J Control Release. 2012 Sep 10;162(2):400-6. doi: 10.1016/j.jconrel.2012.06.032. Epub 2012 Jul 1.
5
Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.阿柔比星热敏脂质体的配方优化提供了在温和热疗下的超快触发释放,从而提高了肿瘤的反应。
J Control Release. 2015 Dec 28;220(Pt A):425-437. doi: 10.1016/j.jconrel.2015.10.056. Epub 2015 Nov 3.
6
MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.磁共振成像对轻度热疗诱导的钆双胺从实体瘤中热敏脂质体释放的特征分析
Invest Radiol. 2008 Dec;43(12):877-92. doi: 10.1097/RLI.0b013e31818768cd.
7
Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronate.一种用于温度触发释放肿瘤靶向剂 Ln(III)-DOTA-苯硼酸酯的脂质体递药系统的研制。
Bioorg Med Chem. 2011 Feb 1;19(3):1123-30. doi: 10.1016/j.bmc.2010.06.036. Epub 2010 Jun 18.
8
Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes.通过cRGD锚定热敏脂质体增强肿瘤中的特异性和药物递送
Pharm Res. 2015 Dec;32(12):3862-76. doi: 10.1007/s11095-015-1746-7. Epub 2015 Jul 23.
9
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.靶向温度敏感磁性脂质体用于热化疗。
J Control Release. 2010 Feb 25;142(1):108-21. doi: 10.1016/j.jconrel.2009.10.002. Epub 2009 Oct 9.
10
Thermosensitive liposomes with higher phase transition temperature for targeted drug delivery to tumor.具有较高相变温度的热敏脂质体用于肿瘤的靶向药物递送。
Int J Pharm. 2014 Nov 20;475(1-2):408-15. doi: 10.1016/j.ijpharm.2014.09.009. Epub 2014 Sep 10.

引用本文的文献

1
Triple synergistic enhancement of breast cancer treatment via chemotherapy, chemodynamic therapy, and tumor starvation therapy driven by lipid-COF nanoparticles.通过脂质共价有机框架纳米颗粒驱动的化疗、化学动力疗法和肿瘤饥饿疗法对乳腺癌治疗的三重协同增强作用
Sci Rep. 2025 Mar 21;15(1):9791. doi: 10.1038/s41598-025-94393-4.
2
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.脂质体纳米药物的进展:创新制剂、治疗应用及精准医学的未来方向
Int J Nanomedicine. 2025 Jan 31;20:1213-1262. doi: 10.2147/IJN.S488961. eCollection 2025.
3
Mild Hyperthermia Enhanced Liposomal Doxorubicin Delivery and CD8 T cell Infiltration in Triple Negative Breast Cancer.
轻度热疗增强脂质体阿霉素在三阴性乳腺癌中的递送及CD8 T细胞浸润
bioRxiv. 2024 Apr 27:2024.04.25.591226. doi: 10.1101/2024.04.25.591226.
4
Liposomes to Cubosomes: The Evolution of Lipidic Nanocarriers and Their Cutting-Edge Biomedical Applications.从脂质体到立方脂质体:脂质纳米载体的演变及其在生物医学中的前沿应用。
ACS Appl Bio Mater. 2024 May 20;7(5):2677-2694. doi: 10.1021/acsabm.4c00153. Epub 2024 Apr 13.
5
Cellular Trojan Horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies.细胞木马启动双金属 Fe-CuMOF 介导的协同铜死亡和铁死亡以对抗恶性肿瘤。
Sci Adv. 2024 Apr 12;10(15):eadk3201. doi: 10.1126/sciadv.adk3201. Epub 2024 Apr 10.
6
A NIR-Activated and Mild-Temperature-Sensitive Nanoplatform with an HSP90 Inhibitor for Combinatory Chemotherapy and Mild Photothermal Therapy in Cancel Cells.一种具有HSP90抑制剂的近红外激活且温度敏感的纳米平台,用于癌细胞的联合化疗和温和光热疗法。
Pharmaceutics. 2023 Aug 31;15(9):2252. doi: 10.3390/pharmaceutics15092252.
7
Review of the Delivery Kinetics of Thermosensitive Liposomes.热敏脂质体给药动力学综述
Cancers (Basel). 2023 Jan 7;15(2):398. doi: 10.3390/cancers15020398.
8
Thermosensitive Liposomes Encapsulating Nedaplatin and Picoplatin Demonstrate Enhanced Cytotoxicity against Breast Cancer Cells.包裹奈达铂和匹铂的热敏脂质体对乳腺癌细胞显示出增强的细胞毒性。
ACS Omega. 2022 Nov 7;7(46):42115-42125. doi: 10.1021/acsomega.2c04525. eCollection 2022 Nov 22.
9
Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience.用于癌症治疗的脂质体药物递送系统:鹿特丹经验
Pharmaceutics. 2022 Oct 11;14(10):2165. doi: 10.3390/pharmaceutics14102165.
10
Selecting ideal drugs for encapsulation in thermosensitive liposomes and other triggered nanoparticles.选择理想的药物封装在热敏脂质体和其他触发的纳米粒子中。
Int J Hyperthermia. 2022;39(1):998-1009. doi: 10.1080/02656736.2022.2086303.